Introduction
Bristol Eye Hospital provides ophthalmic care for the City of Bristol and surrounding areas, a population of approximately 863 000. The corneal clinic has been established for 14 years, and all cases of severe herpetic eye disease are referred here. Furthermore, all patients who have received corneal grafts are followed up in this clinic.
We have surveyed the population with herpetic keratitis seen in the corneal clinic over a period of 2 years. We wished to document the workload generated by patients requiring penetrating keratoplasty (PK) for herpetic keratitis.
Patients, materials and methods Details of the patients studied have been published elsewhere', To summarize, a computerized data base ofall patients seen in the corneal clinic was commenced in August 1984.This was maintained on the University main-frame Multics computer using an XQX editor. Recorded data included all diagnoses and adequate information for retrieval of hospital notes. The data base was augmented and updated on a weekly basis after each clinic, and thus patients were prospectively recruited into the data base.
At the end of July 1986, the data base was searched for all patients with herpetic keratitis. A list of 104 cases was produced, and of these 100 case notes could be located. Thirty-three patients had received corneal grafts; these formed the study population.
The parameters recorded for each patient included patient sex, and age when PK was required for visual rehabilitation. In addition, the number of inpatient days and outpatient visits during the year prior to PK and the 2 years after PK were recorded.
Results
Thirty-three patients had required corneal grafts; there were 19 males and 14 females. Mean age at time of surgery was 55.5 years (58.8 for males, 51.1 for females).
Patients who underwent PK required a mean of6.8 outpatient visits in the year prior to surgery, and a mean of 15.4 visits in the first postoperative year. In the second postoperative year, patients had a mean of 7.8 outpatient attendances.
Patients who required PK spent a mean of 2.8 days as inpatients in the year prior to surgery, and 13.8 days in hospital for PK. In the first postoperative year, a mean of 4.5 days was spent in hospital, but in the second postoperative year this fell to only 1.4 days.
Discussion
Herpes simplex virus (HSV)not only produces disease when it first infects the eye, but also by producing recurrent disease (see reference 2 for a recent review). This study has shown that such recurrent disease produces corneal scarring requiring PK in at least 33% of patients with severe herpetic keratitis. This can only represent a minimum, as further patients in the study group may eventually require PK. The significance of optimal therapy to prevent early critical damage has been stressedt.
The commitment required of the patient with herpetic keratitis when PK is undertaken has previously been commented on 3 , but the extent of this commitment is not mentioned either in ophthalmic reference texts 4 • 5 nor in specialist texts on herpetic eye dlsease".
During the year before PK, our patients required a mean of6.8 outpatient visits and 2.8 days of inpatient treatment. This probably represents a working week for the patient. In the first postoperative year, patients required 15.4 outpatient visits and 4.5 days of inpatient treatment in addition to 13.8 days hospitalization at the time of surgery. This probably represents at least 3 working weeks in addition to any postoperative convalescent time. However, in the second postoperative year, only 7.8 outpatient visits and 1.4 inpatient days were required (one working week). It is not known whether attendances after PK for other conditions (such as keratoconus) would follow a similar pattern.
Whilst it is difficult to calculate the financial cost to the patient, the cost to the National Health Service can be estimated. For similar patients, the cost for an inpatient day is £164 and for an outpatient visit £46 (for the financial year 1985/86). In addition, there is a theatre charge and the transport costs involved in the supply of corneal donor material (£160).
Using these figures, the total cost for each patient with herpetic keratitis requiring PK is £772 in the year prior to PK, £3870 in the year during which the operation is performed, and £588 in the second postoperative year. In view of the documented success of PK in restoring vision in these patients? it would not be ethical to compare the cost-effectiveness ofPK with continued medical therapy.
If 500 per million persons per year is the incidence of herpetic keratitis", and 25% or more progress to severe disease with some visual loss-", then 125 new patients per annum would be classified as having severe herpetic eye disease from an initial population of one million. From our figures, a third will require PK, and thus it is possible to calculate the annual number ofPKs which could be performed for herpetic keratitis. This is approximately 40 per million population.
In view of the generally good results of PK for herpetic keratitis", and with advances in corneal grafting using HLA-matched donor material in these high risk patients 10 • ll it is likely that most if not all these patients could be offered grafts. Our data limits us to those patients 1 year prior to and 2 years after PK, but these patients require 40 donor corneas per year, and will generate 900 bed-days, and 1200 outpatient visits each year per million population. At 1985/86 costing, this represents a total of £209 200. In addition, between 40 and 80 hours of theatre time would be required. These figures may be of use in man-power planning. Thus, if it were to be decided that corneal grafting is to become a procedure mainly performed at regional centres, the above figures would represent resources which would become available for other uses at centres where PK was not done.
